1-20 of 109
leukemia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

Paraskevi Diamanti, Charlotte V. Cox, Benjamin C. Ede, Robert A. Uger, John P. Moppett, Allison Blair
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3694–3708.
https://doi.org/10.1182/bloodadvances.2020003534
Published: 2021
Includes: Supplemental data
Journal Articles

Canonical Wnt: a safeguard and threat for erythropoiesis

Rosa A. Krimpenfort, Micha Nethe
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3726–3735.
https://doi.org/10.1182/bloodadvances.2021004845
Published: 2021
Journal Articles

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

Clinical Trials & Observations
Ifeyinwa Emmanuela Obiorah, Bhavisha A. Patel, Emma M. Groarke, Weixin Wang, Megan Trick, Amanda K. Ombrello, Marcela A. Ferrada, Zhijie Wu, Fernanda Gutierrez-Rodrigues, Jennifer Lotter, Lorena Wilson, Patrycja Hoffmann, Daniela Ospina Cardona, Nisha Patel, Alina Dulau-Florea, Daniel L. Kastner, Peter C. Grayson, David B. Beck, Neal S. Young, Katherine R. Calvo
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3203–3215.
https://doi.org/10.1182/bloodadvances.2021004976
Published: 2021
Includes: Supplemental data
Journal Articles

The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1 + leukemia

Eileen Y. Hu, Priscilla Do, Swagata Goswami, Jessica Nunes, Chi-ling Chiang, Sara Elgamal, Ann M. Ventura, Carolyn Cheney, Kevan Zapolnik, Erich Williams, Rajeswaran Mani, Frank Frissora, Xiaokui Mo, Lorenz Waldmeier, Roger R. Beerli, Haiyong Peng, Christoph Rader, Meixiao Long, Ulf Grawunder, John C. Byrd, Natarajan Muthusamy
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3152–3162.
https://doi.org/10.1182/bloodadvances.2020003276
Published: 2021
Includes: Supplemental data
Journal Articles

Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial

Clinical Trials & Observations
Charlotte M. Niemeyer, Christian Flotho, Daniel B. Lipka, Jan Starý, Claudia Rössig, André Baruchel, Thomas Klingebiel, Concetta Micalizzi, Gérard Michel, Karsten Nysom, Susana Rives, Markus Schmugge Liner, Marco Zecca, Maximilian Schönung, Irith Baumann, Peter Nöllke, Bouchra Benettaib, Noha Biserna, Jennifer Poon, Mathew Simcock, Meera Patturajan, Daniel Menezes, Allison Gaudy, Marry M. van den Heuvel-Eibrink, Franco Locatelli
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2901–2908.
https://doi.org/10.1182/bloodadvances.2020004144
Published: 2021
Includes: Supplemental data
Journal Articles

LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα

Kensaku Kohrogi, Shinjiro Hino, Akihisa Sakamoto, Kotaro Anan, Ryuta Takase, Hirotaka Araki, Yuko Hino, Kazutaka Araki, Tetsuya Sato, Kimitoshi Nakamura, Mitsuyoshi Nakao
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2305–2318.
https://doi.org/10.1182/bloodadvances.2020003521
Published: 2021
Includes: Supplemental data
Journal Articles

Inhibiting autophagy targets human leukemic stem cells and hypoxic AML blasts by disrupting mitochondrial homeostasis

Kaitlyn M. Dykstra, Hannah R. S. Fay, Ashish C. Massey, Neng Yang, Matthew Johnson, Scott Portwood, Monica L. Guzman, Eunice S. Wang
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2087–2100.
https://doi.org/10.1182/bloodadvances.2020002666
Published: 2021
Includes: Supplemental data
Journal Articles

CDX2 regulates ACE expression in blood development and leukemia cells

Reine El Omar, Emmanuelle Julien, Katia Biasch, Blandine Guffroy, Bruno Lioure, Laurent Vallat, Isabelle Gross, Claire Domon-Dell, François Lanza, Christian Gachet, Matteo Negroni, Jean-Noël Freund, Manuela Tavian
Journal: Blood Advances
Blood Adv (2021) 5 (7): 2012–2016.
https://doi.org/10.1182/bloodadvances.2020003563
Published: 2021
Includes: Supplemental data
Journal Articles

Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia

Clinical Trials & Observations
Abhishek Maiti, Courtney D. DiNardo, Sa A. Wang, Jeffrey Jorgensen, Tapan M. Kadia, Naval G. Daver, Nicholas J. Short, Musa Yilmaz, Naveen Pemmaraju, Gautam Borthakur, Prithviraj Bose, Ghayas C. Issa, Alessandra Ferrajoli, Elias J. Jabbour, Nitin Jain, Guillermo Garcia-Manero, Maro Ohanian, Koichi Takahashi, Guillermo Montalban-Bravo, Lucia Masarova, Jan A. Burger, Philip A. Thompson, Srdan Verstovsek, Koji Sasaki, Michael Andreeff, Caitlin R. Rausch, Kathryn S. Montalbano, Sherry Pierce, Wei Qiao, Jing Ning, Hagop M. Kantarjian, Marina Y. Konopleva, Farhad Ravandi
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1876–1883.
https://doi.org/10.1182/bloodadvances.2020003717
Published: 2021
Includes: Supplemental data
Journal Articles

ETV6-FLT3– positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML

Clinical Trials & Observations
Barbara Spitzer, Filemon S. Dela Cruz, Glorymar D. Ibanez Sanchez, Yanming Zhang, Wenbin Xiao, Ryma Benayed, Alina Markova, M. Irene Rodriguez-Sanchez, Nancy Bouvier, Mikhail Roshal, Andrew L. Kung, Neerav Shukla
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1899–1902.
https://doi.org/10.1182/bloodadvances.2020003699
Published: 2021
Journal Articles

Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells

Elina Parri, Heikki Kuusanmäki, Daria Bulanova, Satu Mustjoki, Krister Wennerberg
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1862–1875.
https://doi.org/10.1182/bloodadvances.2020003300
Published: 2021
Includes: Supplemental data
Journal Articles

Deregulated expression of circular RNAs in acute myeloid leukemia

Susanne Lux, Tamara J. Blätte, Bernhard Gillissen, Antje Richter, Sibylle Cocciardi, Sabrina Skambraks, Klaus Schwarz, Hubert Schrezenmeier, Hartmut Döhner, Konstanze Döhner, Anna Dolnik, Lars Bullinger
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1490–1503.
https://doi.org/10.1182/bloodadvances.2020003230
Published: 2021
Includes: Supplemental data
Journal Articles

Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis

Clinical Trials & Observations
Sebastiano Rontauroli, Sara Castellano, Paola Guglielmelli, Roberta Zini, Elisa Bianchi, Elena Genovese, Chiara Carretta, Sandra Parenti, Sebastian Fantini, Selene Mallia, Lara Tavernari, Stefano Sartini, Margherita Mirabile, Carmela Mannarelli, Francesca Gesullo, Annalisa Pacilli, Daniela Pietra, Elisa Rumi, Silvia Salmoiraghi, Barbara Mora, Laura Villani, Andrea Grilli, Vittorio Rosti, Giovanni Barosi, Francesco Passamonti, Alessandro Rambaldi, Luca Malcovati, Mario Cazzola, Silvio Bicciato, Enrico Tagliafico, Alessandro M. Vannucchi, Rossella Manfredini
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1452–1462.
https://doi.org/10.1182/bloodadvances.2020003614
Published: 2021
Includes: Supplemental data
Journal Articles

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Clinical Trials & Observations
Antonio Pierini, Loredana Ruggeri, Alessandra Carotti, Franca Falzetti, Simonetta Saldi, Adelmo Terenzi, Claudio Zucchetti, Gianluca Ingrosso, Tiziana Zei, Roberta Iacucci Ostini, Sara Piccinelli, Samanta Bonato, Sara Tricarico, Antonella Mancusi, Sara Ciardelli, Roberto Limongello, Mara Merluzzi, Mauro Di Ianni, Rita Tognellini, Olivia Minelli, Cristina Mecucci, Maria Paola Martelli, Brunangelo Falini, Massimo Fabrizio Martelli, Cynthia Aristei, Andrea Velardi
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1199–1208.
https://doi.org/10.1182/bloodadvances.2020003739
Published: 2021
Includes: Supplemental data
Journal Articles

Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

Sylvain Mareschal, Anna Palau, Johan Lindberg, Philippe Ruminy, Christer Nilsson, Sofia Bengtzén, Marie Engvall, Anna Eriksson, Anne Neddermeyer, Vinciane Marchand, Monika Jansson, My Björklund, Fabrice Jardin, Mattias Rantalainen, Andreas Lennartsson, Lucia Cavelier, Henrik Grönberg, Sören Lehmann
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1003–1016.
https://doi.org/10.1182/bloodadvances.2020002517
Published: 2021
Includes: Supplemental data
Journal Articles

Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax

Blake S. Moses, Samantha McCullough, Jennifer M. Fox, Bryan T. Mott, Søren M. Bentzen, MinJung Kim, Jeffrey W. Tyner, Rena G. Lapidus, Ashkan Emadi, Michelle A. Rudek, Tami J. Kingsbury, Curt I. Civin
Journal: Blood Advances
Blood Adv (2021) 5 (3): 711–724.
https://doi.org/10.1182/bloodadvances.2020003429
Published: 2021
Includes: Supplemental data
Journal Articles

Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation

Michelle C. Krutein, Matthew R. Hart, Donovan J. Anderson, Jasmin Jeffery, Andriana G. Kotini, Jin Dai, Sylvia Chien, Michaela DelPriore, Sara Borst, Jean Ann Maguire, Deborah L. French, Paul Gadue, Eirini P. Papapetrou, Siobán B. Keel, Pamela S. Becker, Marshall S. Horwitz
Journal: Blood Advances
Blood Adv (2021) 5 (3): 687–699.
https://doi.org/10.1182/bloodadvances.2020002709
Published: 2021
Includes: Supplemental data
Journal Articles

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL –negative MPN in blast phase

Clinical Trials & Observations
Vikas Gupta, James A. Kennedy, Jose-Mario Capo-Chichi, Soyoung Kim, Zhen-Huan Hu, Edwin P. Alyea, Uday R. Popat, Ronald M. Sobecks, Bart L. Scott, Aaron T. Gerds, Rachel B. Salit, H. Joachim Deeg, Ryotara Nakamura, Wael Saber
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5562–5573.
https://doi.org/10.1182/bloodadvances.2020002727
Published: 2020
Includes: Supplemental data
Journal Articles

Naive T-cell depletion in stem cell transplantation

Marie Bleakley
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4980.
https://doi.org/10.1182/bloodadvances.2020001888
Published: 2020
Includes: Supplemental data
Journal Articles

Thioridazine requires calcium influx to induce MLL-AF6 –rearranged AML cell death

Claudia Tregnago, Ambra Da Ros, Elena Porcù, Maddalena Benetton, Manuela Simonato, Luca Simula, Giulia Borella, Katia Polato, Sonia Minuzzo, Giulia Borile, Paola Cogo, Silvia Campello, Alessandro Massi, Romeo Romagnoli, Barbara Buldini, Franco Locatelli, Martina Pigazzi
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4417–4429.
https://doi.org/10.1182/bloodadvances.2020002001
Published: 2020
Includes: Multimedia, Supplemental data